• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙酰肝素酶促进前列腺癌中的骨质破坏和侵袭性。

Heparanase promotes bone destruction and invasiveness in prostate cancer.

作者信息

Zhou Yu, Song Bin, Qin Wei-Jun, Zhang Geng, Zhang Rui, Luan Qi, Pan Tie-Jun, Yang An-Gang, Wang He

机构信息

Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi'an, China.

出版信息

Cancer Lett. 2008 Sep 18;268(2):252-9. doi: 10.1016/j.canlet.2008.04.008. Epub 2008 May 19.

DOI:10.1016/j.canlet.2008.04.008
PMID:18487013
Abstract

Heparanase is an endoglycosidase that plays an important role in angiogenesis and metastasis of cancer. Herein we evaluate the effect of heparanase overexpression on invasiveness and bone destruction in prostate cancer bone metastases. The human prostate cancer cell line PC-3 was stably transfected with a plasmid containing the cDNA for human heparanase or with the vector alone as a control. Overexpression of heparanase did not affect the growth of PC-3 cells, but did promote invasiveness of the cells in an in vitro assay. Both cell types were injected into the tibias of nude mice. Four weeks later, the mice were examined radiologically prior to sacrifice and samples of leg tissue were taken to investigate bone destruction and metastasis. Mice injected with PC-3 cells overexpressing heparanase had more severe bone destruction and larger, more invasive, tumors. These results demonstrate that heparanase overexpression can facilitate tumor invasion and accelerate bone destruction caused by prostate cancer bone metastasis.

摘要

乙酰肝素酶是一种内切糖苷酶,在癌症的血管生成和转移中起重要作用。在此,我们评估乙酰肝素酶过表达对前列腺癌骨转移中侵袭性和骨质破坏的影响。用人乙酰肝素酶cDNA质粒或单独载体作为对照稳定转染人前列腺癌细胞系PC-3。乙酰肝素酶的过表达不影响PC-3细胞的生长,但在体外试验中确实促进了细胞的侵袭性。将两种细胞类型都注射到裸鼠的胫骨中。四周后,在处死小鼠前进行放射学检查,并采集腿部组织样本以研究骨质破坏和转移情况。注射过表达乙酰肝素酶的PC-3细胞的小鼠有更严重的骨质破坏和更大、更具侵袭性的肿瘤。这些结果表明,乙酰肝素酶过表达可促进肿瘤侵袭并加速前列腺癌骨转移引起的骨质破坏。

相似文献

1
Heparanase promotes bone destruction and invasiveness in prostate cancer.乙酰肝素酶促进前列腺癌中的骨质破坏和侵袭性。
Cancer Lett. 2008 Sep 18;268(2):252-9. doi: 10.1016/j.canlet.2008.04.008. Epub 2008 May 19.
2
Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases.原发性乳腺肿瘤中乙酰肝素酶的表达在未检测到骨转移的情况下促进骨吸收。
Cancer Res. 2005 Jul 1;65(13):5778-84. doi: 10.1158/0008-5472.CAN-05-0749.
3
Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.头蛋白的过表达抑制骨溶解性前列腺癌病灶的BMP介导生长。
Bone. 2006 Feb;38(2):154-66. doi: 10.1016/j.bone.2005.07.015. Epub 2005 Aug 26.
4
Function of heparanase in prostate tumorigenesis: potential for therapy.乙酰肝素酶在前列腺肿瘤发生中的作用:治疗潜力
Clin Cancer Res. 2008 Feb 1;14(3):668-76. doi: 10.1158/1078-0432.CCR-07-1866. Epub 2008 Jan 22.
5
Suppression of invasion and metastasis of prostate cancer cells by overexpression of NDRG2 gene.过表达 NDRG2 基因抑制前列腺癌细胞的侵袭和转移。
Cancer Lett. 2011 Nov 1;310(1):94-100. doi: 10.1016/j.canlet.2011.06.015. Epub 2011 Jun 24.
6
[Effect of exogenous expression of heparanase gene on invasive ability of colorectal cancer cell line HT29].[乙酰肝素酶基因外源性表达对大肠癌细胞系HT29侵袭能力的影响]
Ai Zheng. 2005 Dec;24(12):1427-30.
7
Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss.巨噬细胞抑制细胞因子-1在前列腺癌骨转移中的表达可诱导破骨细胞活化并导致体重减轻。
Prostate. 2009 May 1;69(6):652-61. doi: 10.1002/pros.20913.
8
IGF-I secretion by prostate carcinoma cells does not alter tumor-bone cell interactions in vitro or in vivo.前列腺癌细胞分泌的胰岛素样生长因子-I在体外或体内均不会改变肿瘤与骨细胞的相互作用。
Prostate. 2006 Jun 1;66(8):789-800. doi: 10.1002/pros.20379.
9
Maspin reduces prostate cancer metastasis to bone.乳腺丝抑蛋白可减少前列腺癌向骨骼的转移。
Urol Oncol. 2008 Nov-Dec;26(6):652-8. doi: 10.1016/j.urolonc.2007.07.017. Epub 2008 Jan 15.
10
Prostate-specific antigen induces apoptosis of osteoclast precursors: potential role in osteoblastic bone metastases of prostate cancer.前列腺特异性抗原诱导破骨细胞前体细胞凋亡:在前列腺癌成骨性骨转移中的潜在作用。
Prostate. 2006 Nov 1;66(15):1573-84. doi: 10.1002/pros.20375.

引用本文的文献

1
Heparanase inhibitor OGT 2115 induces prostate cancer cell apoptosis via the downregulation of MCL‑1.乙酰肝素酶抑制剂OGT 2115通过下调MCL-1诱导前列腺癌细胞凋亡。
Oncol Lett. 2024 Jan 5;27(2):83. doi: 10.3892/ol.2024.14217. eCollection 2024 Feb.
2
Heparanase 1 Upregulation Promotes Tumor Progression and Is a Predictor of Low Survival for Oral Cancer.乙酰肝素酶1上调促进肿瘤进展,是口腔癌低生存率的一个预测指标。
Front Cell Dev Biol. 2022 Jun 16;10:742213. doi: 10.3389/fcell.2022.742213. eCollection 2022.
3
Heparanase regulates EMT and cancer stem cell properties in prostate tumors.
乙酰肝素酶调节前列腺肿瘤中的上皮-间质转化和癌症干细胞特性。
Front Oncol. 2022 Jul 27;12:918419. doi: 10.3389/fonc.2022.918419. eCollection 2022.
4
promotes invasion and metastasis of gastric cancer by enhancing heparanase expression.促进胃癌的侵袭和转移,增强乙酰肝素酶的表达。
World J Gastroenterol. 2018 Oct 28;24(40):4565-4577. doi: 10.3748/wjg.v24.i40.4565.
5
Heparanase promotes radiation resistance of cervical cancer by upregulating hypoxia inducible factor 1.乙酰肝素酶通过上调缺氧诱导因子1促进宫颈癌的放射抗性。
Am J Cancer Res. 2017 Feb 1;7(2):234-244. eCollection 2017.
6
Heparanase promotes human gastric cancer cells migration and invasion by increasing Src and p38 phosphorylation expression.乙酰肝素酶通过增加Src和p38磷酸化表达促进人胃癌细胞迁移和侵袭。
Int J Clin Exp Pathol. 2014 Aug 15;7(9):5609-21. eCollection 2014.
7
Targeted silencing of heparanase gene by small interfering RNA inhibits invasiveness and metastasis of osteosarcoma cells.小干扰RNA靶向沉默乙酰肝素酶基因可抑制骨肉瘤细胞的侵袭和转移。
J Huazhong Univ Sci Technolog Med Sci. 2011 Jun;31(3):348-352. doi: 10.1007/s11596-011-0379-2. Epub 2011 Jun 14.
8
Heparanase enhances local and systemic osteolysis in multiple myeloma by upregulating the expression and secretion of RANKL.肝素酶通过上调 RANKL 的表达和分泌增强多发性骨髓瘤的局部和全身溶骨性骨病。
Cancer Res. 2010 Nov 1;70(21):8329-38. doi: 10.1158/0008-5472.CAN-10-2179. Epub 2010 Oct 26.